Pyrazole trk kinase inhibitors for the treatment of cancer

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.3, 2007-03, pp. : 351-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolism considerations for kinase inhibitors in cancer treatment

By Duckett Derek R Cameron Michael D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1175-1193

Informa Healthcare

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors in cancer treatment

By Traxler P.M.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. : 571-588

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine kinase inhibitors in cancer treatment (Part II)

By Traxler P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. : 1599-1625

Informa Healthcare

Access to resources Recommend Favorite

Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 575-576

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies to Overcome Resistance to Targeted Protein Kinase Inhibitors in the Treatment of Cancer

By Buschbeck Marcus

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 73-86

Adis International

Access to resources Recommend Favorite